Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 1218, pseudogene (RNU6-1218P)** is a pseudogene of the U6 small nuclear RNA family, annotated in the human genome at chromosome 8[1][3][5][7]. Unlike functional U6 snRNA, which is an essential component of the spliceosome and involved in pre-mRNA splicing[10], RNU6-1218P is a non-functional RNA gene fragment, not transcribed into a functional product. Pseudogenes like RNU6-1218P are often remnants of gene duplication or retrotransposition events and typically do not encode functional RNA or protein. There is currently no evidence that RNU6-1218P is involved in any biological process, disease, drug interaction, or used as a biomarker[1][3][7][9]. It is catalogued in genomic databases solely as a sequence homolog of the genuine U6 snRNA gene, serving as molecular background without known direct biological or therapeutic significance. There is nothing incorrect about this entry, but its function is limited to that of a typical processed pseudogene, with no evidence supporting it as a therapeutic target or having clinical relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1218, pseudogene (RNU6-1218P).